Literature DB >> 10022353

Modelling of factor Xa-inhibitor complexes: a computational flexible docking approach.

M S Rao1, A J Olson.   

Abstract

In order to understand the structural basis of Factor Xa (FXa) specificity, structural complexes of FXa with its synthetic inhibitors are determined using a computational docking approach. The AutoDock suite of programs is used to determine the binding modes of the synthetic inhibitors such as 3- and 4-amidinobenzylphenyl ether (ABP), amidinophenyl pyruvic acid (APPA), diamidinobenzofuranyl ethene (DABE), and DX-9065a 2-(5'-amidino-2'-benzofuranyl)-3-(7'amidino-2'-napthyl)-propionic acid (ABAP) to FXa. The synthetic inhibitors docked in the present study are different in size, nature of linkage, and properties. Two sets of simulations were carried out for synthetic inhibitors docking to FXa. In the first set of simulations, no explicit water molecules were included. In the second set of simulations two explicit solvent molecules were considered. In all the computationally predicted synthetic inhibitor complexes of FXa, the specificity pocket residue Asp-189 is involved in hydrogen bonding with the bound inhibitor. The active site water molecule WAT522 is involved in hydrogen bonding with all the bound inhibitors. The computed energies clearly discriminate the high affinity from low affinity binders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022353     DOI: 10.1002/(sici)1097-0134(19990201)34:2<173::aid-prot3>3.0.co;2-f

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

1.  Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods.

Authors:  W Sippl
Journal:  J Comput Aided Mol Des       Date:  2000-08       Impact factor: 3.686

2.  Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites.

Authors:  Nicolas Le Novère; Thomas Grutter; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

3.  Decoys for docking.

Authors:  Alan P Graves; Ruth Brenk; Brian K Shoichet
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

4.  Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogs.

Authors:  Jyoti Kanwar; Imthiyaz Mohammad; Huanjie Yang; Congde Huo; Tak Hang Chan; Q Ping Dou
Journal:  Int J Mol Med       Date:  2010-08       Impact factor: 4.101

5.  Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors.

Authors:  W Sippl; J M Contreras; I Parrot; Y M Rival; C G Wermuth
Journal:  J Comput Aided Mol Des       Date:  2001-05       Impact factor: 3.686

6.  Factor Xa: simulation studies with an eye to inhibitor design.

Authors:  X Daura; E Haaksma; W F van Gunsteren
Journal:  J Comput Aided Mol Des       Date:  2000-08       Impact factor: 3.686

7.  Automated docking of ligands to an artificial active site: augmenting crystallographic analysis with computer modeling.

Authors:  Robin J Rosenfeld; David S Goodsell; Rabi A Musah; Garrett M Morris; David B Goodin; Arthur J Olson
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

8.  Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.

Authors:  Abhinav Grover; Ashutosh Shandilya; Ankita Punetha; Virendra S Bisaria; Durai Sundar
Journal:  BMC Genomics       Date:  2010-12-02       Impact factor: 3.969

9.  Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.

Authors:  Abhinav Grover; Ashutosh Shandilya; Vibhuti Agrawal; Piyush Pratik; Divya Bhasme; Virendra S Bisaria; Durai Sundar
Journal:  BMC Bioinformatics       Date:  2011-02-15       Impact factor: 3.169

10.  Structure-based activity prediction for an enzyme of unknown function.

Authors:  Johannes C Hermann; Ricardo Marti-Arbona; Alexander A Fedorov; Elena Fedorov; Steven C Almo; Brian K Shoichet; Frank M Raushel
Journal:  Nature       Date:  2007-07-01       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.